Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

Jyothy Lab - Q1FY21 First Cut - ICICI Securities

Posted On: 2020-08-05 09:31:37

(CMP - Rs. 140 MCap - Rs. 5156 crore)

Jyothy Labs posted a healthy set of numbers in a disruptive environment with revenue growth of 4.1% and earnings growth of 40.4%.

Q1FY21 Earnings Summary

- Revenues grew 4.1% led by 6% volume growth. Dishwashing & household insecticide witnessed strong 16.6% & 151.1% growth. Dishwashing segment has seen a strong growth mainly on the back of increasing consumer demand due to heightened hygiene awareness. The higher growth in household insecticide was mainly on account of low base & increased trade inventory at the end of June quarter before the beginning of the season. However, fabric wash segment saw 23.8% decline in sales due to dampened demand conditions for fabric whitener due to reduced 'out of home' activity

- Gross margins contracted 182 bps as the company would not have benefited from low raw material prices due to stocking of old inventory. However, a substantial reduction in marketing spends & cut in other overhead cost led to the operating margins expansion of 233 bps during the quarter. The company reduced the A&P spends by 41% to Rs. 19.8 crore. In terms of percentage of sales, A&P spends were down 350 bps. Net profit witnessed growth of 40.4% largely led by higher operating profit

The company put up a resilient performance in a disruptive times mainly due to filling of trade inventory of household insecticide products before the start of the season & higher sales of hygiene products. Moreover, Jyothy Lab has a strong rural presence, which remain largely insulated from lockdown. We believe the company would have started manufacturing operations quickly within few weeks of lockdown. With the lever of marketing spends, the company was able to protect operating margins. However, we believe the product portfolio of Jyothy lab has always faced stiff competition from large player presence in the category, which has impacted the growth periodically. We are cautious on growth prospects.

We will be coming out with the detailed result update soon.

Shares of JYOTHY LABS LTD. was last trading in BSE at Rs.140.4 as compared to the previous close of Rs. 131. The total number of shares traded during the day was 343025 in over 6005 trades.

The stock hit an intraday high of Rs. 143.75 and intraday low of 132.1. The net turnover during the day was Rs. 47208976.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Mazagon Dock IPO fully subscribed on Day 1 - Angel Broking

Pharma - Sector Thematic - Cardiac: the heartbeat of domestic market - HDFC Securities Institutional Research Desk

Walmart-Tata Retail Deal - Mr. Himanshu Nayyar, YES SECURITIES

HDFC Securities Institutional Research Desk: Chemical Conference Report

Lupin - Launch of Fosaprepitant - Angel Broking

Infosys - Key beneficiary of increased IT spending - Angel Broking

Gateway Distriparks - Holding structure simplified; prepared for next phase of growth - ICICI Securities

Visaka Industries - Demand and pricing tailwinds sustain; maintain a compelling BUY - ICICI Securities

GSK Pharmaceuticals - Analyst call highlights - Sep 28, 2020 - ICICI Securities

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019